Advanced Search
Contact | Corporate | Help

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Sponsors:
  • Ohio State University
  • Genentech
  • Eli Lilly and Company
Phases:
  • Phase II
IndicationsAcronym:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Bevacizumab (drug), Gemcitabine (drug) & Carboplatin (drug)
Enrollment:
45

Additional information about NCT00267696.


SourceSolution © 2008-2012